Photolitec is a new life-sciences company in Buffalo, NY. Our primary offices are located in Amherst and we maintain offices and a research laboratory on the Buffalo Niagara Medical Campus in the heart of the city.
The company is developing new photosensitizing compounds used to identify cancer through medical imaging and treat the disease (a "see and treat" approach). Our compounds are designed to overcome limitations associated with the agents currently on the market. Photolitec's new long-wavelength-absorbing compounds will help to image and treat deeply-seated tumors.
Photolitec is also actively involved in developing new agents for improved tumor imaging, as well as for monitoring tumor resonse after surgery / chemotherapy.